Standex International (SXI) Q4 2024 earnings summary

Executive summary

• Achieved record profit and cash generation in fiscal 2024, with adjusted gross margin at 39.4% (up 90 bps YOY) and adjusted operating margin at 15.8% (up 60 bps YOY), despite a 4.3% Q4 sales decline; fast growth market sales rose 13% year-on-year, reaching $94 million.

• Margin expansion and increased R&D investment fueled future growth, with over 12 new products expected to launch in fiscal 2025, anticipated to add more than 1% to sales growth.

• Four business segments posted operating margins above 20% in Q4, with strong performance in fast growth end markets such as space and defense.

• Free cash flow reached $73 million for FY24, up 9.8% year-on-year, with a free cash flow conversion ratio of 112% of GAAP net income.

• Record R&D investment of $20 million in fiscal 2024, representing 2.8% of sales, with a goal to exceed 3%.

Financial highlights

• Q4 revenue decreased 4.3% year-on-year to $180.2 million, with organic revenue down 9.4% and acquisitions contributing 6.2%.

• Adjusted operating margin for Q4 was 16%, up 60 basis points year-on-year; adjusted operating income was $28.7 million, down 1% year-on-year; adjusted EPS was flat at $1.76.

• FY24 adjusted gross margin reached a record 39.4%, up 90 bps year-on-year.

• Free cash flow for Q4 was $22.2 million, down from $32.28 million a year ago.

• Net cash position at quarter end was $5.3 million, with $154.2 million in cash and equivalents and $148.9 million in long-term debt.

Outlook and guidance

• Fiscal 2025 is expected to see similar or slightly higher revenue and gross margin in Q1, with higher investments in selling, marketing, and R&D.

• Fast growth market sales are projected to grow above 20% and exceed $110 million in fiscal 2025, with over a dozen new products planned for release.

• General market conditions are expected to stabilize in the first half and strengthen in the second half of fiscal 2025.

• Long-term targets by fiscal 2028 reaffirmed: high single-digit organic growth to over $1 billion sales, adjusted operating margin above 19%, ROIC above 15%, and free cash flow conversion around 100% of GAAP net income.